Navigation Links
2 federal public health grants awarded to Weill Cornell Medical College
Date:1/16/2008

NEW YORK (Jan. 16, 2008) -- Two major federal grants have been awarded to Public Health faculty at Weill Cornell Medical College in New York City.

Dr. Kenneth W. Griffin is the recipient of a three-year $1.6 million NIH grant from the National Institute on Drug Abuse (NIDA) for research into the long-term effects of a school-based drug-abuse prevention program previously delivered to urban minority youth attending New York City middle schools. The study will focus on a sample of approximately 3,500 young adults, ages 21 to 23, who participated in a randomized prevention trial during their early teens. In addition to testing the long-term effects of the prevention program on alcohol, tobacco and illicit drug use among the participants as young adults, the study will test whether the effects generalize to a variety of sexual risk behaviors.

Dr. Griffin is associate professor of public health in the Division of Prevention and Health Behavior, Department of Public Health, Weill Cornell Medical College.

Dr. Inmaculada de Melo-Martn is the recipient of a two-year $150,000 National Science Foundation Grant (NSF) for innovative research examining the ways in which the concept of human dignity is used in current debates about contentious biotechnologies such as embryonic stem cell research, human genetic enhancement and the creation of human-nonhuman chimeras. It will provide the first systematic assessment of what several influential scholars and recent national and international science policy documents mean when they say that these technologies threaten human dignity. Thus, the research can play a role in improving dialogue between the sciences and the humanities, and between the sciences and society.

Dr. de Melo-Martn is associate professor of public health in the Division of Medical Ethics, Department of Public Health, Weill Cornell Medical College.

"These awards represent important acknowledgments of the societal value of Dr. Griffin's and Dr. de Melo-Martn's work," says Dr. Alvin I. Mushlin, the Nanette Laitman Professor and Chairman of the Department of Public Health at Weill Cornell. "They are also examples of the diversity in public health research being conducted in the Department."


'/>"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Related biology news :

1. SNM applauds NAS study showing need to restore federal nuclear medicine research funding
2. NOAA proposes federal regulations to protect black abalone
3. How the public perceives biotech
4. Anthony S. Fauci awarded Lasker Award for Public Service
5. Folic acid lowers blood arsenic levels, according to Mailman School of Public Health study
6. BIO-key International Showcasing Innovative Public Safety Solutions at 2007 IACP Conference
7. Mandate for public access to NIH-funded research poised to become law
8. Market testing of dietary supplements and drugs underscores value of USPs public health programs
9. Asthma link to post-traumatic stress disorder, says Mailman School of Public Health study
10. Columbia researchers: Growth of CT scan use may lead to significant public health problem
11. Wireless Public Safety Solution From BIO-key(R) and DaProSystems Links Virginia Law Enforcement Agencies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... NEW YORK , Feb. 8, 2017 /PRNewswire/ ... an individual,s voice to match it against a ... voice such as pitch, cadence, and tone are ... systems require minimal hardware installation, as most PCs ... remotely for different transactions. Voice recognition biometrics are ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 /PRNewswire/ ... point. Driven largely by the confluence of organizations, ... users, distaste for knowledge-based systems (password and challenge ... consumer, industrial, and government systems. The market is ... been a demarcation between consumer and enterprise uses ...
(Date:2/7/2017)... 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... will present at the LEERINK Partners 6th Annual Global ... on Wednesday, February 15, 2017 at 10 a.m. Eastern ... presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  The ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... DIEGO and SAN FRANCISCO ... a privately-held regenerative medicine company, and Beyond Type 1, ... with type 1 diabetes, today announced a grant from ... a functional cure for type 1 and other insulin-requiring ... ViaCyte has been developing innovative stem cell-derived cell replacement ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... acquired Kendall Research Systems, LLC (KRS) clinical development program. KRS is ... interface technology for research and clinical applications. The terms of the transaction were ...
(Date:2/22/2017)... , Feb. 22, 2017 Scientists propose in ... and organ damage in Gaucher and maybe other lysosomal ... and lower costs than current therapies. An ... Medical Center , which also included investigators from the ... report their data Feb. 22. The study was conducted ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... and scientists from around the world, is pleased to announce the 2nd annual ... 23, 2017. This premier, online-only conference focused on the development and advancements in ...
Breaking Biology Technology: